Real-time enrollment status for this egfr mutation positive non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:01 AM UTC
| NCT Number | NCT07315113 |
| Recruiting Status | Recruiting |
| Condition | EGFR Mutation Positive Non-small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Nuvectis Pharma, Inc. |
| Last Updated on CT.gov | July 9, 2026 (4 days ago) |
As of July 13, 2026: Clinical trial NCT07315113 is currently recruiting participants. This clinical trial study for egfr mutation positive non-small cell lung cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Nuvectis Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07315113 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07315113 was last updated 4 days ago (July 9, 2026). HelloStudys verifies this status automatically.